These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 1347986)
1. Correlation of c-erbB-2 protein expression with histologic grade, lymph node involvement and steroid receptor status in human breast tumors. Lampe B; Genz T; Maassen V; Mikorey S; Klosterhalfen T Arch Gynecol Obstet; 1992; 251(1):45-50. PubMed ID: 1347986 [TBL] [Abstract][Full Text] [Related]
2. [C-erbB-2 oncogene amplification in breast cancer in correlation to steroid and epidermal growth factor receptor]. Manavi M; Czerwenka KF; Zeillinger R; Speiser P; Kury F; Steinhart U; Peschke M; Kubista E; Reinold E Zentralbl Gynakol; 1992; 114(2):82-5. PubMed ID: 1350129 [TBL] [Abstract][Full Text] [Related]
3. p53 and c-erbB-2 protein expression in breast carcinomas. An immunohistochemical study including correlations with receptor status, proliferation markers, and clinical stage in human breast cancer. Barbareschi M; Leonardi E; Mauri FA; Serio G; Dalla Palma P Am J Clin Pathol; 1992 Oct; 98(4):408-18. PubMed ID: 1357956 [TBL] [Abstract][Full Text] [Related]
4. Estrogen and progesterone receptor and c-erbB-2 oncoprotein analysis in pure in situ breast carcinoma: an immunohistochemical study. Wilbur DC; Barrows GH Mod Pathol; 1993 Mar; 6(2):114-20. PubMed ID: 8097877 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of oestrogen and progesterone receptors, and c-erbB-2 in carcinoma of the breast in Trinidadian women. Rao AV; Mohammed WA; Ragoonanan C; Omo-Igbinomwanhia NE West Indian Med J; 2002 Mar; 51(1):4-9. PubMed ID: 12089875 [TBL] [Abstract][Full Text] [Related]
6. Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer. van de Vijver MJ; Peterse JL; Mooi WJ; Wisman P; Lomans J; Dalesio O; Nusse R N Engl J Med; 1988 Nov; 319(19):1239-45. PubMed ID: 2903446 [TBL] [Abstract][Full Text] [Related]
7. Amplification of the c-erb B-2 oncogene and prognosis of breast adenocarcinoma. Heintz NH; Leslie KO; Rogers LA; Howard PL Arch Pathol Lab Med; 1990 Feb; 114(2):160-3. PubMed ID: 1967929 [TBL] [Abstract][Full Text] [Related]
8. HER2 as a prognostic factor in breast cancer. Ménard S; Fortis S; Castiglioni F; Agresti R; Balsari A Oncology; 2001; 61 Suppl 2():67-72. PubMed ID: 11694790 [TBL] [Abstract][Full Text] [Related]
9. [Her-2 amplification and p185 expression in invasive breast cancer cells in women]. Titi S Ann Acad Med Stetin; 2006; 52(2):5-12. PubMed ID: 17633393 [TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of c-erbB-2 and estrogen receptor status in human breast cancer. McCann AH; Dervan PA; O'Regan M; Codd MB; Gullick WJ; Tobin BM; Carney DN Cancer Res; 1991 Jun; 51(12):3296-303. PubMed ID: 1674898 [TBL] [Abstract][Full Text] [Related]
11. The prognostic value of p53 and c-erb B-2 immunostaining is overrated for patients with lymph node negative breast carcinoma: a multivariate analysis of prognostic factors in 613 patients with a follow-up of 14-30 years. Reed W; Hannisdal E; Boehler PJ; Gundersen S; Host H; Marthin J Cancer; 2000 Feb; 88(4):804-13. PubMed ID: 10679650 [TBL] [Abstract][Full Text] [Related]
12. Determination of c-erbB-2 protein in primary breast cancer tissue extract using an enzyme immunoassay. Watanabe T; Fukutomi T; Tsuda H; Adachi I; Nanasawa T; Yamamoto H; Abe K Jpn J Cancer Res; 1993 Dec; 84(12):1279-86. PubMed ID: 7904987 [TBL] [Abstract][Full Text] [Related]
13. A retrospective analysis of breast cancer based on outcome differences. Wolman SR; Feiner HD; Schinella RA; Gimotty P; Ownby H; Maloney T; Dawson PJ Hum Pathol; 1991 May; 22(5):475-80. PubMed ID: 1674493 [TBL] [Abstract][Full Text] [Related]
14. An immunohistochemical evaluation of c-erbB-2 expression in human breast carcinoma. Barnes DM; Lammie GA; Millis RR; Gullick WL; Allen DS; Altman DG Br J Cancer; 1988 Oct; 58(4):448-52. PubMed ID: 2849974 [TBL] [Abstract][Full Text] [Related]
15. c-erbB-2 and ras expression levels in breast cancer are correlated and show a co-operative association with unfavorable clinical outcome. Dati C; Muraca R; Tazartes O; Antoniotti S; Perroteau I; Giai M; Cortese P; Sismondi P; Saglio G; De Bortoli M Int J Cancer; 1991 Apr; 47(6):833-8. PubMed ID: 1672666 [TBL] [Abstract][Full Text] [Related]
16. C-erbB-2 oncogene protein in in situ and invasive lobular breast neoplasia. Porter PL; Garcia R; Moe R; Corwin DJ; Gown AM Cancer; 1991 Jul; 68(2):331-4. PubMed ID: 1676930 [TBL] [Abstract][Full Text] [Related]
17. VEGF expression is associated with negative estrogen receptor status in patients with breast cancer. Fuckar D; Dekanić A; Stifter S; Mustać E; Krstulja M; Dobrila F; Jonjić N Int J Surg Pathol; 2006 Jan; 14(1):49-55. PubMed ID: 16501835 [TBL] [Abstract][Full Text] [Related]
18. Enzyme-linked immunosorbent assay of HER-2/neu gene product (p185) in breast cancer: its correlation with sex steroid receptors, cathepsin D and histologic grades. Marsigliante S; Muscella A; Ciardo V; Barker S; Leo G; Baker V; Mottaghi A; Vinson GP; Storelli C Cancer Lett; 1993 Dec; 75(3):195-206. PubMed ID: 7906196 [TBL] [Abstract][Full Text] [Related]
19. Amplification and protein over-expression of the neu/HER-2/c-erbB-2 protooncogene in human breast carcinomas: relationship to loss of gene sequences on chromosome 17, family history and prognosis. Børresen AL; Ottestad L; Gaustad A; Andersen TI; Heikkilä R; Jahnsen T; Tveit KM; Nesland JM Br J Cancer; 1990 Oct; 62(4):585-90. PubMed ID: 1977466 [TBL] [Abstract][Full Text] [Related]
20. Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading. Berger MS; Locher GW; Saurer S; Gullick WJ; Waterfield MD; Groner B; Hynes NE Cancer Res; 1988 Mar; 48(5):1238-43. PubMed ID: 2893663 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]